Article
Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia
24 Jul 2019
Abstract excerpt
BACKGROUND: There is no prognostic test to ascertain whether cervical intraepithelial neoplasias (CINs) regress or progress. The majority of CINs regress in young women, and treatments increase the risk of adverse pregnancy outcomes. We investigated the ability of a DNA methylation panel (the S5 classifier) to discriminate between outcomes among young women with untreated CIN grade 2 (CIN2). METHODS: Baseline...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
